4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001104659-22-075788
Chief Operating Officer sold 7,714 shares at $13.00 ($100,282)
From the SEC's structured data for this filing
Trades in this filing
Dowden Nathan J · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-06-27 | Sale : show line 1 in the form | −7,714 | $13.00 | $100,282 | 64,893 | D |
| Open-market sales · 7,714 sh · avg $13.00 · $100,282 | ||||||
Loading xslF345X03/tm2220048-2_4seq1.xml…